United States · Bill · S
S. 1388 (117th)
Prescription Pricing for the People Act of 2021
Introduced
27 April 2021
Last action
—
Status
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Prescription Pricing for the People Act of 20 21 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 27 April 2021
Introduced in Senate (PDF)
Introduced in Senate · EN · 27 April 2021
Introduced in Senate
summary · EN · 27 April 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/senate-bill/1388
- Open data entity: https://api.congress.gov/v3/bill/117/s/1388